Cargando…
How much leeway is there to relax COVID-19 control measures?
Following successful non-pharmaceutical interventions (NPI) aiming to control COVID-19, many jurisdictions reopened their economies and borders. As little immunity had developed in most populations, re-establishing higher contact carried substantial risks, and therefore many locations began to see r...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970422/ https://www.ncbi.nlm.nih.gov/pubmed/33971429 http://dx.doi.org/10.1016/j.epidem.2021.100453 |
_version_ | 1783666424862998528 |
---|---|
author | Anderson, Sean C. Mulberry, Nicola Edwards, Andrew M. Stockdale, Jessica E. Iyaniwura, Sarafa A. Falcao, Rebeca C. Otterstatter, Michael C. Janjua, Naveed Z. Coombs, Daniel Colijn, Caroline |
author_facet | Anderson, Sean C. Mulberry, Nicola Edwards, Andrew M. Stockdale, Jessica E. Iyaniwura, Sarafa A. Falcao, Rebeca C. Otterstatter, Michael C. Janjua, Naveed Z. Coombs, Daniel Colijn, Caroline |
author_sort | Anderson, Sean C. |
collection | PubMed |
description | Following successful non-pharmaceutical interventions (NPI) aiming to control COVID-19, many jurisdictions reopened their economies and borders. As little immunity had developed in most populations, re-establishing higher contact carried substantial risks, and therefore many locations began to see resurgence in COVID-19 cases. We present a Bayesian method to estimate the leeway to reopen, or alternatively the strength of change required to re-establish COVID-19 control, in a range of jurisdictions experiencing different COVID-19 epidemics. We estimated the timing and strength of initial control measures such as widespread distancing and compared the leeway jurisdictions had to reopen immediately after NPI measures to later estimates of leeway. Finally, we quantified risks associated with reopening and the likely burden of new cases due to introductions from other jurisdictions. We found widely varying leeway to reopen. After initial NPI measures took effect, some jurisdictions had substantial leeway (e.g., Japan, New Zealand, Germany) with > 0.99 probability that contact rates were below 80% of the threshold for epidemic growth. Others had little leeway (e.g., the United Kingdom, Washington State) and some had none (e.g., Sweden, California). For most such regions, increases in contact rate of 1.5–2 fold would have had high (> 0.7) probability of exceeding past peak sizes. Most jurisdictions experienced June–August trajectories consistent with our projections of contact rate increases of 1–2-fold. Under such relaxation scenarios for some regions, we projected up to [Formula: see text] 100 additional cases if just one case were imported per week over six weeks, even between jurisdictions with comparable COVID-19 risk. We provide an R package covidseir to enable jurisdictions to estimate leeway and forecast cases under different future contact patterns. Estimates of leeway can establish a quantitative basis for decisions about reopening. We recommend a cautious approach to reopening economies and borders, coupled with strong monitoring for changes in transmission. |
format | Online Article Text |
id | pubmed-7970422 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79704222021-03-18 How much leeway is there to relax COVID-19 control measures? Anderson, Sean C. Mulberry, Nicola Edwards, Andrew M. Stockdale, Jessica E. Iyaniwura, Sarafa A. Falcao, Rebeca C. Otterstatter, Michael C. Janjua, Naveed Z. Coombs, Daniel Colijn, Caroline Epidemics Article Following successful non-pharmaceutical interventions (NPI) aiming to control COVID-19, many jurisdictions reopened their economies and borders. As little immunity had developed in most populations, re-establishing higher contact carried substantial risks, and therefore many locations began to see resurgence in COVID-19 cases. We present a Bayesian method to estimate the leeway to reopen, or alternatively the strength of change required to re-establish COVID-19 control, in a range of jurisdictions experiencing different COVID-19 epidemics. We estimated the timing and strength of initial control measures such as widespread distancing and compared the leeway jurisdictions had to reopen immediately after NPI measures to later estimates of leeway. Finally, we quantified risks associated with reopening and the likely burden of new cases due to introductions from other jurisdictions. We found widely varying leeway to reopen. After initial NPI measures took effect, some jurisdictions had substantial leeway (e.g., Japan, New Zealand, Germany) with > 0.99 probability that contact rates were below 80% of the threshold for epidemic growth. Others had little leeway (e.g., the United Kingdom, Washington State) and some had none (e.g., Sweden, California). For most such regions, increases in contact rate of 1.5–2 fold would have had high (> 0.7) probability of exceeding past peak sizes. Most jurisdictions experienced June–August trajectories consistent with our projections of contact rate increases of 1–2-fold. Under such relaxation scenarios for some regions, we projected up to [Formula: see text] 100 additional cases if just one case were imported per week over six weeks, even between jurisdictions with comparable COVID-19 risk. We provide an R package covidseir to enable jurisdictions to estimate leeway and forecast cases under different future contact patterns. Estimates of leeway can establish a quantitative basis for decisions about reopening. We recommend a cautious approach to reopening economies and borders, coupled with strong monitoring for changes in transmission. Published by Elsevier B.V. 2021-06 2021-03-18 /pmc/articles/PMC7970422/ /pubmed/33971429 http://dx.doi.org/10.1016/j.epidem.2021.100453 Text en Crown Copyright © 2021 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Anderson, Sean C. Mulberry, Nicola Edwards, Andrew M. Stockdale, Jessica E. Iyaniwura, Sarafa A. Falcao, Rebeca C. Otterstatter, Michael C. Janjua, Naveed Z. Coombs, Daniel Colijn, Caroline How much leeway is there to relax COVID-19 control measures? |
title | How much leeway is there to relax COVID-19 control measures? |
title_full | How much leeway is there to relax COVID-19 control measures? |
title_fullStr | How much leeway is there to relax COVID-19 control measures? |
title_full_unstemmed | How much leeway is there to relax COVID-19 control measures? |
title_short | How much leeway is there to relax COVID-19 control measures? |
title_sort | how much leeway is there to relax covid-19 control measures? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970422/ https://www.ncbi.nlm.nih.gov/pubmed/33971429 http://dx.doi.org/10.1016/j.epidem.2021.100453 |
work_keys_str_mv | AT andersonseanc howmuchleewayistheretorelaxcovid19controlmeasures AT mulberrynicola howmuchleewayistheretorelaxcovid19controlmeasures AT edwardsandrewm howmuchleewayistheretorelaxcovid19controlmeasures AT stockdalejessicae howmuchleewayistheretorelaxcovid19controlmeasures AT iyaniwurasarafaa howmuchleewayistheretorelaxcovid19controlmeasures AT falcaorebecac howmuchleewayistheretorelaxcovid19controlmeasures AT otterstattermichaelc howmuchleewayistheretorelaxcovid19controlmeasures AT janjuanaveedz howmuchleewayistheretorelaxcovid19controlmeasures AT coombsdaniel howmuchleewayistheretorelaxcovid19controlmeasures AT colijncaroline howmuchleewayistheretorelaxcovid19controlmeasures |